Toman fish supplement tested to boost albumin in TB patients
NCT ID NCT07186478
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tests I-FALMIN, a supplement made from toman fish, in 112 adults with pulmonary tuberculosis and low albumin levels. Participants take the supplement or a placebo for one day alongside standard TB treatment. Researchers will check if albumin levels and body mass index improve over 57 days, aiming to see if this natural supplement can aid recovery.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
I-FALMIN (standardized extract from toman fish, containing natural albumin)
What this could lead to
If it works, this could provide a natural, affordable supplement to improve albumin levels and recovery in tuberculosis patients.
What could go wrong
This is an early-stage trial with only 112 participants, so results may not apply broadly. The supplement is tested for just one day, and long-term benefits or risks are unknown.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PULMONARY TUBERCULOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
RSUD Wahidin Sudirohusodo
Makassar, South Sulawesi, 90245, Indonesia